Andrew Metry
Sheffield, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in Egypt.
Journal: Applied health economics and health policy
Published: January 23, 2025
Cost-effectiveness analysis of the geko™ device (an NMES technology) in managing venous leg ulcers in UK healthcare settings.
Journal: International wound journal
Published: May 31, 2024
Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis.
Journal: Health technology assessment (Winchester, England)
Published: October 16, 2023
Early Cost-Utility Analysis of Ataluren and Eteplirsen in the Treatment of Duchenne Muscular Dystrophy in Egypt.
Journal: Value in health regional issues
Published: May 02, 2023
A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: August 03, 2021
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study.
Journal: PharmacoEconomics
Published: June 20, 2021
Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.
Journal: Health technology assessment (Winchester, England)
Published: June 18, 2021
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.
Journal: Health technology assessment (Winchester, England)
Published: June 16, 2021
Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies.
Journal: PharmacoEconomics
Published: May 18, 2021
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study.
Journal: PharmacoEconomics
Published: March 30, 2021
Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
Journal: Health technology assessment (Winchester, England)
Published: March 25, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026